Our New Firmagon Website is currently in development and we apologise for any inconvenience. In the meantime we hope the resources below are helpful.
Adverse Event reporting information can be found in footer
Our New Firmagon Website is currently in development and we apologise for any inconvenience. In the meantime we hope the resources below are helpful.
Request a Meeting
New license indication:
Firmagon® is a gonadotrophin releasing hormone (GnRH) antagonist indicated for the treatment of adult male patients with advanced hormone-dependent prostate cancer in the UK, also in combination with radiotherapy and as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone-dependent prostate cancer 1,2
Learn more about Firmagon® and the MOA by downloading this leaflet
A quick reference poster with an easy-to-use guide to dosing and administering Firmagon® to your patients, starting with their initial treatment through to subsequent maintenance doses.
Learn how to best administer a Firmagon® injection by watching our instructional video with Leanne McCourt Macmillan Urology Nurse Specialist. This quick demonstration illustrates the precise technique for administering a deep subcutaneous injection into the abdomen.Watch the video now for a comprehensive understanding of the dosing and administration process.
Firmagon is a deep subcutaneous injection administered to the abdominal region. It should be administered at a slow and steady pace over 30 seconds.
Injection sites should be varied and not be in areas where the patient will be exposed to pressure e.g. not close to waistband/ belt. Treatment should be continued after initiation and it should only be administered by a healthcare professional.
The injection site should be kept clean and patients should avoid rubbing the area. If your patient experiences a reaction at the injection site, it can be managed with paracetamol or ibuprofen or cooling methods e.g. ice packs.
Please watch this video for more information and guidance.
Watch this video to learn more about Firmagon’s Mode of Action and the differences between antagonists and agonists.
A simple guide for prostate cancer patients to help them keep a record of their treatment plan and PSA levels.
This booklet is for patient and provides useful information about Firmagon as well as more general advice about prostate cancer and how to access further support.
Help your colleagues and patients understand the different prostate cancer stages, grading scores and how to interpret them.
Job Code: UK-FN-2300034 - Date of preparation: January 2024
We use cookies (including third party cookies) to collect data while you use this website in order to make it work, keep it secure and comply with regulations. We’d also like your consent to use cookies so we can provide you with tailored content and advertising and analyse how you and other people use the website.
Select “On” to consent to our use of these cookies and continue to the website, or select “Off” to control which types of cookies we use. You can read more about cookies in our Privacy Policy.
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in away that does not directly identify anyone. For more information on how these cookies work, please see our Privacy Policy.